General disclosures
GRI 2: General Disclosures 2021
| GRI Standard and Disclosure | Reference | |||
|
2-1 |
Organizational details |
|||
|
2-2 |
Entities included in the organization’s sustainability reporting |
|||
|
2-3 |
Reporting period, frequency and contact point |
|||
|
2-4 |
Restatements of information |
|||
|
2-5 |
External assurance |
|||
|
2-6 |
Activities, value chain and other business relationships |
Fundamental Information about the Group |
||
|
2-7 |
Employees |
|||
|
2-9 |
Governance structure and composition |
Statement on Corporate Governance |
||
|
2-10 |
Nomination and selection of the highest governance body |
Objectives of the Supervisory Board |
||
|
2-11 |
Chair of the highest governance body |
|||
|
2-12 |
Role of the highest governance body in overseeing the management of impacts |
Report of the Supervisory Board |
||
|
2-13 |
Delegation of responsibility for managing impacts |
|||
|
2-14 |
Role of the highest governance body in sustainability reporting |
|||
|
2-15 |
Conflicts of interest |
|||
|
2-17 |
Collective knowledge of the highest governance body |
|||
|
2-18 |
Evaluation of the performance of the highest governance body |
|||
|
2-19 |
Remuneration policies |
|||
|
2-20 |
Process to determine remuneration |
|||
|
2-22 |
Statement on sustainable development strategy |
|||
|
2-23 |
Policy commitments |
S4-1 (Health and safety of our patients) S4-1 (Access to our products and services and access to (quality) information) |
||
|
2-24 |
Embedding policy commitments |
Information on corporate governance practices |
||
|
2-25 |
Processes to remediate negative impacts |
Report on Risks and Opportunities S4-1 (Health and safety of our patients) S4-1 (Access to our products and services and access to (quality) information) S4-3 (Health and safety of our patients) S4-4 (Health and safety of our patients) S4-4 (Access to our products and services and access to (quality) information) |
||
|
2-26 |
Mechanisms for seeking advice and raising concerns |
|||
|
2-27 |
Compliance with laws and regulations |
|||
|
2-28 |
Membership associations |
|||
|
2-29 |
Approach to stakeholder engagement |
S4-1 (Health and safety of our patients) S4-1 (Access to our products and services and access to (quality) information) S4-2 (Health and safety of our patients) S4-2 (Access to our products and services and access to (quality) information) |
||
|
2-30 |
Collective bargaining agreements |
|||
GRI 3: Material Topics 2021
| GRI Standard and Disclosure | Reference | |||
|
3-1 |
Process to determine material topics |
|||
|
3-2 |
List of material topics |
|||
Economic standards
GRI 201: Economic Performance 2016
| GRI Standard and Disclosure | Reference | |||
|
201: 3-3 |
Management of material topics |
Statement on Corporate Governance Report on Risks and Opportunities S4-2 (Health and safety of our patients) S4-2 (Access to our products and services and access to (quality) information) S4-4 (Health and safety of our patients) S4-4 (Access to our products and services and access to (quality) information) S4-5 (Health and safety of our patients) S4-5 (Access to our products and services and access to (quality) information) |
||
|
201-1 |
Direct economic value generated and distributed |
|||
|
201-2 |
Financial implications and other risks and opportunities due to climate change |
|||
|
201-3 |
Defined benefit plan obligations and other retirement plans |
|||
|
201-4 |
Financial assistance received from government |
|||
GRI 203: Indirect Economic Impacts 2016
| GRI Standard and Disclosure | Reference | |||
|
203: 3-3 |
Management of material topics |
S4-2 (Health and safety of our patients) S4-2 (Access to our products and services and access to (quality) information) S4-4 (Health and safety of our patients) S4-4 (Access to our products and services and access to (quality) information) S4-5 (Health and safety of our patients) S4-5 (Access to our products and services and access to (quality) information) |
||
|
203-2 |
Significant indirect economic impacts |
S4-4 (Health and safety of our patients) S4-4 (Access to our products and services and access to (quality) information) |
||
GRI 205: Anti-corruption 2016
| GRI Standard and Disclosure | Reference | |||
|
205: 3-3 |
Management of material topics |
|||
|
205-1 |
Operations assessed for risks related to corruption |
|||
|
205-2 |
Communication and training about anti-corruption policies and procedures |
|||
|
205-3 |
Confirmed incidents of corruption and actions taken |
|||
GRI 206: Anti-competitive Behavior 2016
| GRI Standard and Disclosure | Reference | |||
|
206-1 |
Legal actions for anti-competitive behavior, anti-trust, and monopoly practices |
|||
Environmental standards
GRI 301: Materials 2016
| GRI Standard and Disclosure | Reference | |||
|
301: 3-3 |
Management of material topics |
|||
|
301-1 |
Materials used by weight or volume |
|||
|
301-2 |
Recycled input materials used |
|||
|
301-3 |
Reclaimed products and their packaging materials |
|||
GRI 302: Energy 2016
| GRI Standard and Disclosure | Reference | |||
|
302: 3-3 |
Management of material topics |
|||
|
302-1 |
Energy consumption within the organization |
|||
|
302-3 |
Energy intensity |
|||
|
302-4 |
Reduction of energy consumption |
|||
|
302-5 |
Reductions in energy requirements of products and services |
|||
GRI 303:
| GRI Standard and Disclosure | Reference | |||
|
303: 3-3 |
Management of material topics |
|||
|
303-1 |
Interactions with water as a shared resource |
|||
|
303-3 |
Water withdrawal |
|||
GRI 305: Emissions 2016
| GRI Standard and Disclosure | Reference | |||
|
305: 3-3 |
Management of material topics |
E2-1 (Substances of concern and substances of very high concern) E2-2 (Substances of concern and substances of very high concern) E2-3 (Substances of concern and substances of very high concern) |
||
|
305-1 |
Direct (Scope 1) GHG emissions |
|||
|
305-2 |
Energy indirect (Scope 2) GHG emissions |
|||
|
305-3 |
Other indirect (Scope 3) GHG emissions |
|||
|
305-4 |
GHG emissions intensity |
|||
|
305-5 |
Reduction of GHG emissions |
|||
|
305-6 |
Emissions of ozone-depleting substances (ODS) |
E2-5 (Substances of concern and substances of very high concern) |
||
|
305-7 |
Nitrogen oxides (NOx), sulfur oxides (SOx), and other significant air emissions |
|||
GRI 306: Waste 2020
| GRI Standard and Disclosure | Reference | |||
|
306: 3-3 |
Management of material topics |
|||
|
306-1 |
Waste generation and significant waste-related impacts |
|||
|
306-2 |
Management of significant waste-related impacts |
|||
|
306-3 |
Waste generated |
|||
|
306-4 |
Waste diverted from disposal |
|||
|
306-5 |
Waste directed to disposal |
|||
GRI 306: Effluents and Waste 2016
Social standards
GRI 401: Employment 2016
| GRI Standard and Disclosure | Reference | |||
|
401: 3-3 |
Management of material topics |
|||
|
401-1 |
New employee hires and employee turnover |
|||
|
401-3 |
Parental leave |
|||
GRI 402: Labor/Management Relations 2016
| GRI Standard and Disclosure | Reference | |||
|
402: 3-3 |
Management of material topics |
|||
GRI 403: Occupational Health and Safety 2018
| GRI Standard and Disclosure | Reference | |||
|
403: 3-3 |
Management of material topics |
|||
|
403-1 |
Occupational health and safety management system |
|||
|
403-2 |
Hazard identification, risk assessment, and incident investigation |
|||
|
403-4 |
Worker participation, consultation, and communication on occupational health and safety |
|||
|
403-5 |
Worker training on occupational health and safety |
|||
|
403-6 |
Promotion of worker health |
|||
|
403-7 |
Prevention and mitigation of occupational health and safety impacts directly linked by business relationships |
|||
|
403-8 |
Workers covered by an occupational health and safety management system |
|||
|
403-9 |
Work-related injuries |
|||
|
403-10 |
Work-related ill health |
|||
GRI 404: Training and Education 2016
| GRI Standard and Disclosure | Reference | |||
|
404: 3-3 |
Management of material topics |
|||
|
404-2 |
Programs for upgrading employee skills and transition assistance programs |
|||
|
404-3 |
Percentage of employees receiving regular performance and career development reviews |
|||
GRI 405: Diversity and Equal Opportunity 2016
| GRI Standard and Disclosure | Reference | |||
|
405: 3-3 |
Management of material topics |
|||
|
405-1 |
Diversity of governance bodies and employees |
|||
|
405-2 |
Ratio of basic salary and remuneration of women to men |
|||
GRI 406: Non-discrimination 2016
| GRI Standard and Disclosure | Reference | |||
|
406: 3-3 |
Management of material topics |
S4-1 (Health and safety of our patients) S4-1 (Access to our products and services and access to (quality) information) S4-2 (Health and safety of our patients) S4-2 (Access to our products and services and access to (quality) information) S4-4 (Health and safety of our patients) S4-4 (Access to our products and services and access to (quality) information) S4-5 (Health and safety of our patients) S4-5 (Access to our products and services and access to (quality) information) |
||
|
406-1 |
Incidents of discrimination and corrective actions taken |
|||
GRI 407: Freedom of Association and Collective Bargaining 2016
| GRI Standard and Disclosure | Reference | |||
|
407: 3-3 |
Management of material topics |
|||
|
407-1 |
Operations and suppliers in which the right to freedom of association and collective bargaining may be at risk |
|||
GRI 408: Child Labor 2016
| GRI Standard and Disclosure | Reference | |||
|
408: 3-3 |
Management of material topics |
|||
|
408-1 |
Operations and suppliers at significant risk for incidents of child labor |
|||
GRI 409: Forced or Compulsory Labor 2016
| GRI Standard and Disclosure | Reference | |||
|
409: 3-3 |
Management of material topics |
|||
|
409-1 |
Operations and suppliers at significant risk for incidents of forced or compulsory labor |
|||
GRI 416: Customer Health and Safety 2016
| GRI Standard and Disclosure | Reference | |||
|
416: 3-3 |
Management of material topics |
Report on Risks and Opportunities S4-1 (Health and safety of our patients) S4-1 (Access to our products and services and access to (quality) information) |
||
|
416-1 |
Assessment of the health and safety impacts of product and service categories |
S4-1 (Health and safety of our patients) S4-1 (Access to our products and services and access to (quality) information) S4-4 (Health and safety of our patients) S4-4 (Access to our products and services and access to (quality) information) S4-5 (Health and safety of our patients) S4-5 (Access to our products and services and access to (quality) information) |
||
|
416-2 |
Incidents of non-compliance concerning the health and safety impacts of products and services |
Report on Risks and Opportunities S4-4 (Health and safety of our patients) S4-4 (Access to our products and services and access to (quality) information) |
||
GRI 417: Marketing and Labeling 2016
GRI 418: Customer Privacy 2016
Additional material topics
Clinical studies
| GRI Standard and Disclosure | Reference | |||
|
3-3 |
Management of material topics |
S4-1 (Health and safety of our patients) S4-2 (Health and safety of our patients) |
||
Animal welfare
| GRI Standard and Disclosure | Reference | |||
|
3-3 |
Management of material topics |
|||
Access to health
Prices of medicines
Product-related crime
| GRI Standard and Disclosure | Reference | |||
|
3-3 |
Management of material topics |
S4-1 (Health and safety of our patients) S4-2 (Health and safety of our patients) |
||
Bioethics
| GRI Standard and Disclosure | Reference | |||
|
3-3 |
Management of material topics |
|||
Digital ethics
| GRI Standard and Disclosure | Reference | |||
|
3-3 |
Management of material topics |
|||